Global Post-Traumatic Stress Disorder Therapeutics Industry to Reach $10.68 Billion by 2026 - Antidepressants Play a ...GlobeNewswire (press release)Based on the class of drug, the global post-traumatic stress disorder therapeutics market is segmented into antidepressants, anti-anxiety drugs, other drug classes (Alpha-1 & Alpha-2 Receptor Antagonists, Atypical Antipsychotics, and Anticonvulsants ...and more »